Health
Oxford-Astra COVID vaccine shows dual immune action: Researcher – BNN
A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.
A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen.
The vaccine increased levels of both protective neutralizing antibodies and immune T-cells that target the virus, according to the study organizers. The results were published Monday in The Lancet medical journal.
We are seeing very good immune responses, not just on neutralizing antibo…
-
General20 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
General18 hours agoVote counting begins for Townsville mayoral by-election
-
Noosa News23 hours agoQueensland GPs to be able to diagnose adults with attention deficit hyperactivity disorder from December 1
-
Noosa News24 hours agoThe ‘gun’ shearer still setting a cracking pace at 85